FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011407029> ?p ?o ?g. }

• W2011407029 endingPage "e3533" @default.
• W2011407029 startingPage "e3533" @default.
• W2011407029 abstract "To systematically review the effect of folic acid based homocysteine lowering on cardiovascular outcomes in people with kidney disease.Systematic review and meta-analysis.Medline, Embase, the Cochrane Library, and ClinicalTrials.gov to June 2011.Randomised trials in people with non-dialysis dependent chronic kidney disease or end stage kidney disease or with a functioning kidney transplant reporting at least 100 patient years of follow-up and assessing the effect of folic acid based homocysteine lowering therapy. No language restrictions were applied.Two reviewers independently extracted data on study setting, design, and outcomes using a standardised form. The primary endpoint was cardiovascular events (myocardial infarction, stroke, and cardiovascular mortality, or as defined by study author). Secondary endpoints included the individual composite components, all cause mortality, access thrombosis, requirement for renal replacement therapy, and reported adverse events, including haematological and neurological events. The effect of folic acid based homocysteine lowering on outcomes was assessed with meta-analysis using random effects models.11 trials were identified that reported on 4389 people with chronic kidney disease, 2452 with end stage kidney disease, and 4110 with functioning kidney transplants (10,951 participants in total). Folic acid based homocysteine therapy did not prevent cardiovascular events (relative risk 0.97, 95% confidence interval 0.92 to 1.03, P = 0.326) or any of the secondary outcomes. There was no evidence of heterogeneity in subgroup analyses, including those of kidney disease category, background fortification, rates of pre-existing disease, or baseline homocysteine level. The definitions of chronic kidney disease varied widely between the studies. Non-cardiovascular events could not be analysed as few studies reported these outcomes.Folic acid based homocysteine lowering does not reduce cardiovascular events in people with kidney disease. Folic acid based regimens should not be used for the prevention of cardiovascular events in people with kidney disease." @default.
• W2011407029 created "2016-06-24" @default.
• W2011407029 creator A5024768204 @default.
• W2011407029 creator A5027520502 @default.
• W2011407029 creator A5035786059 @default.
• W2011407029 creator A5046112080 @default.
• W2011407029 creator A5054084985 @default.
• W2011407029 creator A5056130529 @default.
• W2011407029 creator A5081702551 @default.
• W2011407029 creator A5087067945 @default.
• W2011407029 creator A5087474773 @default.
• W2011407029 creator A5088788555 @default.
• W2011407029 date "2012-06-13" @default.
• W2011407029 modified "2023-10-14" @default.
• W2011407029 title "The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis" @default.
• W2011407029 cites W1545416473 @default.
• W2011407029 cites W1558007173 @default.
• W2011407029 cites W1601416041 @default.
• W2011407029 cites W1703458018 @default.
• W2011407029 cites W1854187713 @default.
• W2011407029 cites W1922576014 @default.
• W2011407029 cites W1964499377 @default.
• W2011407029 cites W1970787886 @default.
• W2011407029 cites W1975434204 @default.
• W2011407029 cites W1990033119 @default.
• W2011407029 cites W1995931698 @default.
• W2011407029 cites W1996233154 @default.
• W2011407029 cites W2017152548 @default.
• W2011407029 cites W2021836023 @default.
• W2011407029 cites W2026907823 @default.
• W2011407029 cites W2031068759 @default.
• W2011407029 cites W2034020222 @default.
• W2011407029 cites W2039418122 @default.
• W2011407029 cites W2048144298 @default.
• W2011407029 cites W2050634863 @default.
• W2011407029 cites W2051246657 @default.
• W2011407029 cites W2053009660 @default.
• W2011407029 cites W2061790801 @default.
• W2011407029 cites W2090279199 @default.
• W2011407029 cites W2102238862 @default.
• W2011407029 cites W2102935853 @default.
• W2011407029 cites W2106884519 @default.
• W2011407029 cites W2107193384 @default.
• W2011407029 cites W2109544293 @default.
• W2011407029 cites W2115135910 @default.
• W2011407029 cites W2116089455 @default.
• W2011407029 cites W2123886132 @default.
• W2011407029 cites W2130956156 @default.
• W2011407029 cites W2135170120 @default.
• W2011407029 cites W2139488526 @default.
• W2011407029 cites W2151049989 @default.
• W2011407029 cites W2151623352 @default.
• W2011407029 cites W2151899671 @default.
• W2011407029 cites W2156098321 @default.
• W2011407029 cites W2157823046 @default.
• W2011407029 cites W2160341956 @default.
• W2011407029 cites W2167820532 @default.
• W2011407029 cites W2169871578 @default.
• W2011407029 cites W2171205761 @default.
• W2011407029 cites W2188754018 @default.
• W2011407029 cites W2230430502 @default.
• W2011407029 cites W273711101 @default.
• W2011407029 cites W94192723 @default.
• W2011407029 doi "https://doi.org/10.1136/bmj.e3533" @default.
• W2011407029 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3374481" @default.
• W2011407029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22695899" @default.
• W2011407029 hasPublicationYear "2012" @default.
• W2011407029 type Work @default.
• W2011407029 sameAs 2011407029 @default.
• W2011407029 citedByCount "85" @default.
• W2011407029 countsByYear W20114070292012 @default.
• W2011407029 countsByYear W20114070292013 @default.
• W2011407029 countsByYear W20114070292014 @default.
• W2011407029 countsByYear W20114070292015 @default.
• W2011407029 countsByYear W20114070292016 @default.
• W2011407029 countsByYear W20114070292017 @default.
• W2011407029 countsByYear W20114070292018 @default.
• W2011407029 countsByYear W20114070292019 @default.
• W2011407029 countsByYear W20114070292020 @default.
• W2011407029 countsByYear W20114070292021 @default.
• W2011407029 countsByYear W20114070292022 @default.
• W2011407029 countsByYear W20114070292023 @default.
• W2011407029 crossrefType "journal-article" @default.
• W2011407029 hasAuthorship W2011407029A5024768204 @default.
• W2011407029 hasAuthorship W2011407029A5027520502 @default.
• W2011407029 hasAuthorship W2011407029A5035786059 @default.
• W2011407029 hasAuthorship W2011407029A5046112080 @default.
• W2011407029 hasAuthorship W2011407029A5054084985 @default.
• W2011407029 hasAuthorship W2011407029A5056130529 @default.
• W2011407029 hasAuthorship W2011407029A5081702551 @default.
• W2011407029 hasAuthorship W2011407029A5087067945 @default.
• W2011407029 hasAuthorship W2011407029A5087474773 @default.
• W2011407029 hasAuthorship W2011407029A5088788555 @default.
• W2011407029 hasBestOaLocation W20114070291 @default.
• W2011407029 hasConcept C126322002 @default.
• W2011407029 hasConcept C127413603 @default.
• W2011407029 hasConcept C168563851 @default.
• W2011407029 hasConcept C177713679 @default.

• next